Nathanael is a Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School and an Investigator at the Dana-Farber Cancer Institute. Previously, he was Director of Biological Chemistry at the Genomics Institute of the Novartis Research Foundation. Nathanael’s research focuses on the discovery of small molecules that impact biological pathways important in cancer. These efforts have produced numerous first-in-class kinase inhibitors that have become widely used to understand complex biology and have also inspired drug discovery programs. Nathanael’s research has been recognized by many awards including the Meyenburg Cancer Research Award, the American Chemical Society Award for Outstanding Research in Biological Chemistry, and the AACR Award for Team Science. Nathanael received his PhD from the University of California at Berkeley. Nathanael is a founder of Syros Pharmaceuticals and a co-founder of C4 Therapeutics.